Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 15;26(1):28.
doi: 10.1007/s10048-025-00810-1.

Early-onset Parkinson's disease in a patient with a rare homozygous pathogenic GBA1 variant and no Gaucher disease symptoms

Affiliations

Early-onset Parkinson's disease in a patient with a rare homozygous pathogenic GBA1 variant and no Gaucher disease symptoms

Juliana Cordovil Cotrin et al. Neurogenetics. .

Abstract

Parkinson's disease (PD) is a multifaceted neurodegenerative disorder with both non-motor and motor symptoms. Variants in the glucosylceramidase beta 1 (GBA1) gene are the strongest genetic risk factor for PD, while homozygous or compound heterozygous variants in this gene classically cause Gaucher disease (GD). This study presents an early-onset PD patient with a homozygous GBA1 deletion. Whole-exome sequencing (WES) was performed, and the identified variant was validated via Sanger sequencing. The variant was classified according to ACMG guidelines and ClinGen updates. The patient, a Brazilian female of mixed ethnicity, exhibited the full spectrum of classical motor and non-motor PD symptoms without evident hallmarks of GD. The identified homozygous GBA1 variant (NM_000157.4:c.222_224del; p.T75del; rs761621516) has a very low global allele frequency (0.00003284) and is associated with reduced enzymatic activity. This variant exhibits a founder effect among individuals of African descent. This case highlights an intricate genotype-phenotype landscape for GBA1 variants, underscoring the role of homozygous GBA1 variants in PD pathogenesis.

Keywords: GBA1; Early-onset Parkinson’s disease; Gaucher disease; Parkinson’s disease; Whole exome sequencing.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

References

    1. Lees AJ, Hardy J, Revesz T (2009) Parkinson's disease. Lancet 373(9680):2055-66. https://doi.org/10.1016/S0140-6736(09)60492-X . Erratum in: Lancet. 2009 Aug 29;374(9691):684
    1. Velez-Pardo C, Lorenzo-Betancor O, Jimenez-Del-Rio M, Moreno S, Lopera F, Cornejo-Olivas M et al (2019) The distribution and risk effect of GBA variants in a large cohort of PD patients from Colombia and Peru. Parkinsonism Relat Disord 63:204–208. https://doi.org/10.1016/j.parkreldis.2019.01.030 - DOI - PubMed - PMC
    1. Salles P, Tirapegui JM, Chaná-Cuevas P (2024) Genetics of Parkinson's disease: Dominant forms and GBA. Neurology Perspectives 2267–0496. https://doi.org/10.1016/j.neurop.2024.100153 .
    1. Menozzi E, Schapira AHV (2021) Exploring the Genotype-Phenotype Correlation in GBA-Parkinson Disease: Clinical Aspects, Biomarkers, and Potential Modifiers. Front Neurol. https://doi.org/10.3389/fneur.2021.694764 - DOI - PubMed - PMC
    1. Vieira SRL, Mezabrovschi R, Toffoli M, Del Pozo SL, Menozzi E, Mullin S et al (2024) Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson’s Disease. Mov Disord. https://doi.org/10.1002/mds.30006 - DOI - PubMed - PMC

LinkOut - more resources